Merit Medical completed the acquiistion of the dialysis product portfolio and biosentry product from AngioDynamics for $100m.

Merit Medical, a global manufacturer and marketer of healthcare technology, completed the acquiistion of the dialysis product portfolio and biosentry product from AngioDynamics, a medical technology company focused on restoring healthy blood flow in the body’s vascular system, for $100m. “We are selectively investing to expand our product portfolio in key strategic markets that leverage our existing commercial footprint. These acquisitions strengthen our position in the dialysis and biopsy markets, and expand the foundation of our growing specialty dialysis device offering, which includes WRAPSODY™ Cell-Impermeable Endoprosthesis, HeRO® Graft, and the Surfacer System devices. Many dialysis patients rely on these solutions to receive vital therapies. Combining this broad portfolio of interventional solutions within Merit will allow us to leverage our physician relationships and commercial infrastructure to serve more patients in the multi-billion dialysis market,” Fred P. Lampropoulos, Merit Chairman and CEO.